Global Pharmacokinetics Services Market to Reach $1.4 Billion by 2030
The global market for Pharmacokinetics Services estimated at US$853.5 Million in the year 2022, is projected to reach a revised size of US$1.4 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2022-2030. Small Molecules, one of the segments analyzed in the report, is projected to record 6.2% CAGR and reach US$1.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Large Molecules segment is readjusted to a revised 8% CAGR for the next 8-year period.The U.S. Market is Estimated at $249.7 Million, While China is Forecast to Grow at 6.2% CAGR
The Pharmacokinetics Services market in the U.S. is estimated at US$249.7 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$249.2 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 5.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.Select Competitors (Total 34 Featured) -
- Biologics Consulting Group, Inc.
- Certara L.P.
- Charles River Laboratories International, Inc.
- Creative Bioarray
- Eurofins Scientific, Inc.
- Evotec AG
- Frontage Labs
- GVK Biosciences Private Limited
- LGC Limited
- Pacific BioLabs
- Parexel International Corporation
- Pharmaceutical Product Development, LLC
- Product Development, LLC (Jaguar Holding Company I, LLC)
- SGS SA
- Shanghai Medicilon Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Biologics Consulting Group, Inc.
- Certara L.P.
- Charles River Laboratories International, Inc.
- Creative Bioarray
- Eurofins Scientific, Inc.
- Evotec AG
- Frontage Labs
- GVK Biosciences Private Limited
- LGC Limited
- Pacific BioLabs
- Parexel International Corporation
- Pharmaceutical Product Development, LLC
- Product Development, LLC (Jaguar Holding Company I, LLC)
- SGS SA
- Shanghai Medicilon Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 89 |
Published | May 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 853.5 Million |
Forecasted Market Value ( USD | $ 1400 Million |
Compound Annual Growth Rate | 6.4% |
Regions Covered | Global |